Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.12B.
ENTERPRISE VALUE (EV)
$2.12B
GeneDx Holdings Corp.
Market Cap
$2.13B
Enterprise Value (EV)
$2.12B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| GeneDx Holdings Corp. (WGS) | $2.13B | $2.12B |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | $2.12B |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | $2.14B |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | $1.97B |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | $2.27B |
| Pharvaris N.V. (PHVS)vs › | $2.17B | $1.81B |
| Alvotech (ALVO)vs › | $2.08B | $3.39B |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | $2.14B |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | $2.02B |
| Vericel Corporation (VCEL)vs › | $2.05B | $2.02B |
Market Cap
$2.13B
Total Debt
$95.90M
Cash
$105.00M
Enterprise Value
$2.12B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
